LEXINGTON, Mass. – N-of-One, Inc., the leading provider of clinical interpretation for precision medicine in oncology, today announced an agreement with Dartmouth-Hitchcock Medical Center in Lebanon, NH to provide clinical interpretation for Dartmouth-Hitchcock’s Next-Generation Sequencing tests as part of Norris Cotton Cancer Center’s comprehensive molecular diagnostics and treatment program. Financial terms of the agreement are […]

SAN JOSE, Calif. – Analytical laboratories standardized on the Waters® Empower® Chromatography Data System (CDS) now have a wider choice of Thermo Scientific chromatography systems and modules which can be integrated into this environment. Users of Thermo Scientific Dionex UltiMate 3000 series UHPLC and HPLC systems can now drive Thermo Scientific Dionex Corona Veo charged […]

SAN DIEGO — A new high-content screening software platform enables cancer researchers to uncover more about basic and advanced cellular function to accelerate cell-based research. The Thermo Scientific HCS Studio 2.0 is a high-content quantitative imaging and analysis software platform for a range of cancer research applications, including angiogenesis and migration/invasion, as well as the […]

SAN DIEGO — Knowledge of driver mutations is essential to research and development in the pharmaceutical industry for the identification of novel populations and discovery of new cancer drug targets. Gene over-expression is one of the prevalent cancer driver events, but cancer transcriptome expression data generated in labs around the world are difficult to collect, […]

SAN DIEGO, California, and HILDEN, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced two important new product launches which address workflow challenges in next-generation sequencing (NGS) applications. QIAGEN will present these and several other innovative solutions for NGS applications at the American Association for Cancer Research (AACR) Annual Meeting from April […]

ST LOUIS, MO – Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, today released the latest commercial version of the Broad Institute’s Genome Analysis Toolkit (GATK). GATK 3 provides new functionality and best practices to tackle modern challenges in next-generation sequencing (NGS) data analysis. “The Broad Institute has described […]

SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced new products that can be applied directly to the discovery and translation of genomic variation in blood and tissue associated with cancer. The expanded portfolio leverages the company’s industry-leading next-generation sequencing (NGS) and microarray scanning systems to deliver sample-to-data solutions for basic and clinical cancer research. New […]

MUNICH — Waters Corporation (NYSE: WAT) today unveiled two new data analysis software packages for proteomics and metabolomics/lipidomics analyses: Progenesis® QI and Progenesis QI for Proteomics. These new releases of the highly acclaimed software packages are an early result of Waters’ acquisition of Nonlinear Dynamics Ltd., the world leader in ‘omics data analysis software. Progenesis […]

Hawthorne, CA and Rutherford, NJ — Cancer Genetics, Inc. (Nasdaq: CGIX) and BioDiscovery, Inc. have announced expansion of the Nexus Copy Number Discovery platform in CGI research to uncover novel biomarkers which are predictive of cancer outcomes. “Cancer Genetics has been able to leverage the Nexus Copy Number platform’s unique ability to quickly digest large […]

PALO ALTO, Calif. and LEXINGTON, Mass. — Syapse, the leading provider of software for bringing omics data into routine medical use, and N-of-One, the leading provider of clinical interpretation for precision medicine in oncology, today announced a partnership to make N-of-One’s clinical interpretation available to hospitals and laboratories through interfaces in the Syapse platform. This […]